000 | 01138 a2200337 4500 | ||
---|---|---|---|
005 | 20250516144547.0 | ||
264 | 0 | _c20131125 | |
008 | 201311s 0 0 eng d | ||
022 | _a1523-1747 | ||
024 | 7 |
_a10.1038/jid.2013.186 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpoendlin, Julia | |
245 | 0 | 0 |
_aSpironolactone may reduce the risk of incident rosacea. _h[electronic resource] |
260 |
_bThe Journal of investigative dermatology _cOct 2013 |
||
300 |
_a2480-2483 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 |
_aDiuretics _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aRosacea _xepidemiology |
650 | 0 | 4 |
_aSpironolactone _xtherapeutic use |
700 | 1 | _aVoegel, Johannes J | |
700 | 1 | _aJick, Susan S | |
700 | 1 | _aMeier, Christoph R | |
773 | 0 |
_tThe Journal of investigative dermatology _gvol. 133 _gno. 10 _gp. 2480-2483 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/jid.2013.186 _zAvailable from publisher's website |
999 |
_c22677527 _d22677527 |